The questionnaire submitted to the company is below, partially pre-filled on the base on the information collected by the OpenCorporation staff.
ELI LILLY AND COMPANY did not fill the questionnaire.
Registry
1. Ragione sociale
ELI LILLY AND COMPANY
2. Report submitted by the company management or trade union / employee representatives
No
3. Ruolo ricoperto in azienda da parte di chi compila
- KeyRole - Chairman
- KeyRole - CEO
- KeyRole - Human Resources
- KeyRole - CSR/ESG
- KeyRole - Industrial relations
- KeyRole - Communication Public Relations
- EWC/Trade Union/Worker Representative
- Other
4. Global Ultimate Ownership (GUO)
ELI LILLY AND COMPANY
5. Paese (GUO)
United States of America
6. Eventuale impresa controllante
No data fulfill your filter criteria
7. Forma giuridica
- Limited liability company with share capital divided into units
- Limited liability company
- Listed liability company with share capital divided into units
8. È una SE (Societas Europaea)?
No answer
9. LEI (Legal Entity Identifier)
FRDRIPF3EKNDJ2CQJL29
10. BVD Codice identificativo
US350470950
11. ID nazionale
35-0470950
12. Numero Registro Imprese
-
13. Partita IVA
35-0470950
14. Partita IVA europea
-
15. Sede Legale
United States of America
16. Numero di azionisti
25
17. Informazioni sugli azionisti principali
No data fulfill your filter criteria
18. Numero di sussidiarie
252
19. Città
INDIANAPOLIS
20. Paese
United States of America
21. Sito Web
www.lilly.com
22. ISO Codice Paese
US
23. Borsa principale
New York Stock Exchange (NYSE)
24. Numero ISIN
US5324571083
25. Simbolo Ticker
LLY
26. Dichiarazioni e trattati riconosciuti dal Paese dove ha sede legale
Universal Declaration of Human Rights
Yes
European Convention on Human Rights (ECHR)
No
Charter of Fundamental Rights of CDFL Workers (Strasbourg Charter 1989)
No
Charter of Fundamental Rights of the European Union EU CFR (Nice Charter 2000)
No
Treaty on the Functioning of the European Union TFEU
No
Registered office in an OECD country
No
ILO C029 - Forced Labour Convention, 1930 (No. 29)
No
ILO C087 - Freedom of Association and Protection of the Right to Organise Convention, 1948 (No. 87)
No
ILO C098 - Right to Organise and Collective Bargaining Convention, 1949 (No. 98)
No
ILO C100 - Equal Remuneration Convention, 1951 (No. 100)
No
ILO C105 - Abolition of Forced Labour Convention, 1957 (No. 105)
Yes
ILO C111 - Discrimination (Employment and Occupation) Convention, 1958 (No. 111)
No
ILO C138 - Minimum Age Convention, 1973 (No. 138)
No
ILO C182 - Worst Forms of Child Labour Convention, 1999 (No. 182)
Yes
Governance
27. Numero componenti nel Consiglio di Amministrazione (CDA)
-
28. Numero direttori indipendenti nel CDA
-
29. Numero donne nel CDA
-
30. Dualità del CEO (Chief executive Officer)
-
31. Come è composta la Governance?
- Doesn't answer
- Board of Directors
- Board of Directors and supervisory board
- Board of directors plus supervisory board with presence of workers
- Board of Directors plus Board of Statutory Auditors
- Board of directors plus audit with external professionals
32. Compenso totale del CEO
15048322
33. Retribuzione compensativa del CEO
1.222.706,807
34. Data del compenso
2018/12/31
35. Il Compenso del CEO è legato anche alla dimensione ambientale e sociale?
-
36. Management
Current number of Directors and Managers
73
Name of the current Chief Executive Officer
Mr Patrik Jonsson
Gender
M
Date of birth
1974
Country
United States of America
Professional profile of the Chief Executive Officer
President, Lilly USA
Sanctions to the Chief Executive Officer
Yes
Number of companies where the CEO has a role
1
Sector Employment
37. Attività economiche
Primary NACE code
2120
Description of primary NACE code
Manufacture of pharmaceutical preparations
Secondary NACE code
7211
Description of secondary NACE code
Research and experimental development on biotechnology
Brief description of activity
The company, with registered head office located in Indianapolis, United States, is a global pharmaceutical company engaged in the discovery, development, manufacture, and sale of pharmaceutical products. It was founded by Eli Lilly in 1876.The company is committed in developing a growing portfolio of best-in-class and first-in-class pharmaceutical products that help people live longer, healthier and more active lives. It offers neuroscience products that are used for the treatment of schizophrenia, bipolar mania, and maintenance; depression and diabetic peripheral neuropathic pain; attention-deficit hyperactivity disorder in children, adolescents, and adults; bulimia and obsessive-compulsive disorder; Parkinson's disease; bipolar depression; stress urinary incontinence; and pre-menstrual dysphoric disorder. The company also provides endocrine products, including injectable human insulin analogs and oral agents for the treatment of diabetes and osteoporosis in post-menopausal women and men for fracture; and an injectable for the treatment of human growth hormone deficiency and idiopathic short stature. In addition, the company manufactures oncology products that are used for the treatment of pancreatic cancer, bladder cancer, metastatic breast cancer, nonsmall cell lung cancer, ovarian cancer, and malignant pleural mesothelioma; and animal health products comprising cattle feed additives that controls and prevents coccidiosis, performance enhancers and antibiotics used to treat respiratory diseases, anticoccidial agents, antibiotics used to control enteric infections, and parasiticide for use on cattle and premises.Other offers include cardiovascular agents for use as an adjunct to percutaneous coronary intervention, including patients undergoing angioplasty and atherectomy or stent placement, as well as for the treatment of adults with sepsis at high risk of death; anti-infectives to treat staphylococcal and bacterial infections; and other pharmaceutical products for the treatment of erectile dysfunction.The company is one of the world's largest pharmaceutical corporations. It is also one of the oldest and leading pharmaceutical companies in the United States. The company has approximately 43,000 employees worldwide and it markets its medicines in 143 countries. The company has clinical research operations conducted in more than 50 countries, research and development facilities located in nine countries, and manufacturing plants located in 13 countries.The company's mission is to create and deliver superior health care solutions in order to provide customers around the world with optimal clinical and economic outcomes.
38. Occupazione in EU27
Workers (2020)
-
Workers (2019)
-
Workers (2018)
-
Workers (2017)
-
39. Occupazione mondo
Workers [2020]
35000
Workers [2019]
33625
Workers [2018]
38680
Workers [2017]
40655
40. Occupazione femminile mondo (in % su totale mondo)
Workers (2020)
-
Workers (2019)
-
Workers (2018)
-
Workers (2017)
-
Social Dialogue
41. Rispetto alle GUFs (Global Union Federations) avete esperienze di pratiche di:
Social dialogue
-
Rights of information and consultation of employees or their representatives
-
Employee participation
-
GFA Global Framework Agreement
-
42. Rispetto alle ETUFs avete esperienze di pratiche di:
Social dialogue
-
Rights of information and consultation of employees or their representatives
-
Employee participation
-
Collective bargaining
-
43. Nel Paese in cui l'azienda ha sede legale ci sono delle restrizioni alle Libertà sindacali?
No
44. Quali direttive sono applicate alle sedi nella UE 27?
Directive 80/987/EEC related to the protection of employees in the event of the insolvency of their employer
Yes
Directive 89/391/EEC related to improvements in the safety and health of workers at work
Yes
Directive 98/59/EC relating to collective redundancies
Yes
Directive 2000/43/EC on equal treatment between persons irrespective of racial or ethnic origin
Yes
Directive 2000/78/EC for equal treatment in employment and occupation
Yes
Directive 2001/23/EC relating to the safeguarding of employees' rights in the event of transfers of undertakings
Yes
Council Directive 2001/86/EC supplementing the Statute for a European company with regard to the involvement of employees
Yes
Directive 2002/14/EC establishing a general framework for informing and consulting employees
Yes
Directive 2002/73/EC on the principle of equal treatment for men and women
Yes
Council Directive 2003/72/EC on the Statute for a European Cooperative Society with regard to the involvement of employees
Yes
Directive 2005/56/EC of the European Parliament and of the Council on cross-border mergers of limited liability companies
Yes
Directive 2009/38/EC on the establishment of a European Works Council
Yes
Directive 2004/25/EC on takeover bids
Yes
Directive 2011/35/EU concerning mergers of public limited liability companies
Yes
45. L'Azienda è associata ad una organizzazione datoriale?
-
46. Contratti collettivi applicati
GFA - Global Framework Agreement (GFA)
No
Transnational agreements (TNCAs)
No
Transnational agreements by sector (e.g. Bangladesh Accord) or by company (e.g. Global works councils)
No
Agreement to set up the EWC or a representative body in the case of Societas Europaea
Yes
Joint statements
-
Collective labour agreement in all countries in which it operates and where expected Company or supplementary collective labour agreement
-
Collective agreements on remote work
-
47. In caso di accordo istitutivo di Cae o di un un organo di rappresentanza in caso di Societas Europaea (SE)
The text of the Agreement shall be made public
Yes
Was the Agreement signed by a European Trade Union Federation (ETUF) or by trade unions affiliated to it?
-
48. Inserire Link all'Accordo CAE se disponibile
49. In caso di Accordi Transnazionali
The text of the Agreement shall be made public
-
Was the Agreement signed by a Global Trade Union Federation (GUFs) or by trade unions affiliated to it?
-
50. Quali sono gli organismi di informazione e consultazione esistenti in ambito UE 27?
National information and consultation bodies under Directive 2002/14
Yes, in all company sites
National trade union information and consultation bodies under Directive 2002/14
Yes, in all company sites
Workers' health and safety representative within the meaning of Directive 89/391
Yes, in all company sites
Workers' representatives within the meaning of Directives 98/59 on collective redundancies and 2001/23 on the transfer of undertakings
Yes, in all company sites
Social Responsibility
51. Applicate Standard GRI Global reporting initiative?
- Non-response
- No
- Yes, GRI - G4
- Yes, GRI standards
- Citing_GRI
52. Indicare qui il link al database su GRI Reporting
-
53. Pubblicate il Bilancio Sociale/Codice di condotta?
-
54. Pubblicate il Bilancio Integrato?
No answer
55. Standard ISO applicati
ISO 9000 - Quality Management (from 9001 to 9004)
-
ISO 14000 - Environmental Management
-
ISO 26000 - Social responsibility
No answer
ISO 50001 - Energy Management
-
ISO 22000 - Food safety management
-
ISO 20121 - Sustainable events
-
ISO 37001 - Anti-bribery management systems
-
ISO 45001 - Occupational health and safety
-
ISO 20400 - Sustainable Procurement
-
ISO/PAS 45005 - General guidelines for safe working during the COVID-19 pandemic
-
56. Altri standard applicati
Eco-Management and Audit Scheme (EMAS)
-
Forest Stewardship Council (FSC)
-
MCERTS (Environment Agency's Monitoring Certification Scheme)
-
Carbon Disclosure Project (CDP)
No answer
57. Certificazioni sociali e altri standard di RSI applicati
SA8000 Social Accountability
No answer
ILO Tripartite Declaration of Principles concerning Multinational Enterprises and Social Policy
-
OECD Guidelines for Multinational Enterprises
Yes
OECD Principles for Corporate Governance
-
58. Adottata il Global Compact?
Yes
59. Adottate SDGs (Social Development Goals)?
No answer
60. Applicate la Direttiva 95/2014 sulla comunicazione di informazioni di carattere non finanziario?
-
61. Se adottate linee guida OCSE, avete istanze presentate ai punti di contatto nazionali?
-
62. Se non applicate gli standard GRI ma avete predisposto un bilancio sociale/Codice di condotta, trattate di tutti i seguenti temi (trasparenza, rapporti con i fornitori, rapporti con il personale, rapporti con il pubblico, riduzione rischi ambientali, molestie morali e sessuali?
-
63. Se non adottate gli standard GRI ma avete predisposto un Bilancio Sociale/Codice di Condotta, sono stati coinvolti tutti i seguenti attori/stakeholders: organizzazioni sindacali, amministrazioni locali, associazioni di consumatori, rappresentanze dei lavoratori, ONG e rappresentanti della società civile?
-
64. Le politiche di CSR/ESG sono applicate anche a operazioni nazionali, operazioni internazionali, catena di fornitura e outsourcing, distribuzione, franchising, assistenza post vendita?:
-
65. Quali sono gli strumenti utilizzati per verificare il rispetto delle politiche di CSR/ESG lungo la filiera?
- Non-response
- None
- External Audit
- Internal control
66. Adottate o promuovete pratiche di whistleblowing?
-
67. Inserire URL della pagina web sulla policy di whistleblowing
-
68. Partecipazione a ranking
- Global 100 Most Sustainable Corporations
- Global CSR RepTrak 100
- BrandZ Top 100 Most Valuable US Brands
- The World's Best Multinational Workplaces Fortune/Top Employers/Glassdoor best places to work
- The Gartner Supply Chain Top 25
- The World's Most Innovative Companies
- The DiversityInc Top 50 Companies
- Best Global Websites
- Green Ranking Global Top 500
- Green Ranking Global Top 100
69. Indicatori RepRisk
Indicatore che misura l'esposizione di Multinazionali al rischio di impatto ambientale, sociale e di governance (rischi ESG)
RepRisk indicator (last month)
34
OpenCorporation processing on RepRisk Indicator (last month)
66
Peak RepRisk Indicator (Last 2 years)
37
% RepRisk Environment
19
% Social RepRisk
27
RepRisk Governance %
54
Job Conditions
70. Avete una policy sulla formazione?
-
71. Numero medio di ore di formazione/dipendente nell’ultimo anno
-
72. Applicate programmi di skill management e lifelong learning per l'occupabilità continua dei dipendenti?
-
73. Avete una policy a tutela del diritto alla salute e alla sicurezza nei luoghi di lavoro dove opera l'azienda?
-
74. Avete una policy a tutela del diritto alla salute e alla sicurezza nei luoghi di lavoro lungo filiera?
-
75. Numero di infortuni totale (ultimo anno disponibile)
-
76. Numero di infortuni mortale (ultimo anno disponibile)
-
77. Realizzate la valutazione dei rischi psicosociali e di stress lavoro correlato?
-
78. Riconoscimento di benefit aziendali
Supplementary pension plans
-
Health/additional health
-
Insurance for employees and families
-
Training and support for mobility
-
Hourly/work flexibility
-
Loans/loan repayments
-
Equal opportunities
-
Parental support
-
Reconciling life and work
-
Possibility of bringing children to work in case of need
-
Grant/Refund for registration at the Fitness Centres/Open Sports Facilities
-
Contribution to transport costs incurred by employees
-
Incentive for non-polluting means of transport
-
Corporate Car
-
PC/laptop/telephone
-
Measures to combat poverty or social exclusion
-
Welfare extended to the territory
-
Finance
79. Il bilancio di esercizio/consolidato è pubblico?
-
80. Se sì, con quale livello di dettaglio?
- Non-response
- Reclassification item
- Reclassification detail
- Detail detailing financial investments and participations
81. Controllare, integrare o fornire dati quantitativi relativi a (dati in euro, migliaia)
Total assets [2020]
38.002.710,964
Total assets [2019]
34.970.718,458
Total assets [2018]
38.347.928,274
Total assets [2017]
37.506.058,519
Equity capital [2020]
4.597.508,94
Equity capital [2019]
2.320.545,077
Equity capital [2018]
8.584.013,142
Equity capital [2017]
9.665.808,487
Revenues (Net Sales) [2020]
19.998.218,572
Revenues (Net Sales) [2019]
19.867.814,587
Revenues (Net Sales) [2018]
18.771.431,589
Revenues (Net Sales) [2017]
16.654.554,404
Cost of production [2020]
3.389.619,733
Cost of production [2019]
3.105.394,743
Cost of production [2018]
2.683.579,434
Cost of production [2017]
2.401.735,198
labour costs [2020]
0
labour costs [2019]
0
labour costs [2018]
0
labour costs [2017]
0
Other operating expenses [2020]
11.548.535,645
Other operating expenses [2019]
12.265.267,754
Other operating expenses [2018]
12.889.338,483
Other operating expenses [2017]
12.081.301,716
Gross profit [2020]
16.608.598,839
Gross profit [2019]
16.762.419,844
Gross profit [2018]
16.087.852,155
Gross profit [2017]
14.252.819,205
R&D Research & Development [2020]
4.959.419,342
R&D Research & Development [2019]
4.980.417,241
R&D Research & Development [2018]
4.411.526,161
R&D Research & Development [2017]
4.249.313,608
Cash Flow [2020]
6.110.018,972
Cash Flow [2019]
8.944.989,593
Cash Flow [2018]
4.349.430,123
Cash Flow [2017]
1.745.852,367
Added value [2020]
0
Added value [2019]
0
Added value [2018]
0
Added value [2017]
0
Gross operating margin (Ebitda) [2020]
6.122.650,387
Gross operating margin (Ebitda) [2019]
6.037.476,307
Gross operating margin (Ebitda) [2018]
4.725.237,794
Gross operating margin (Ebitda) [2017]
4.087.552,524
Amortization, depreciation and write-downs [2020]
1.062.587,193
Amortization, depreciation and write-downs [2019]
1.540.324,217
Amortization, depreciation and write-downs [2018]
1.526.724,122
Amortization, depreciation and write-downs [2017]
1.916.035,034
Operating result (EBIT) [2020]
5.060.063,194
Operating result (EBIT) [2019]
4.497.152,09
Operating result (EBIT) [2018]
3.198.513,672
Operating result (EBIT) [2017]
2.171.517,49
Interests [2020]
293.048,819
Interests [2019]
356.596,094
Interests [2018]
211.790,286
Interests [2017]
187.609,505
extraordinary items [2020]
0
extraordinary items [2019]
3.276.215,488
extraordinary items [2018]
-82.008,692
extraordinary items [2017]
-3.917.036,329
Pre-tax result [2020]
5.891.862,218
Pre-tax result [2019]
4.687.467,23
Pre-tax result [2018]
3.214.059,516
Pre-tax result [2017]
1.921.788,392
Taxes [2020]
844.430,439
Taxes [2019]
559.017,342
Taxes [2018]
309.344,822
Taxes [2017]
-1.825.065,269
Fiinancial P/L [2020]
831.799,024
Fiinancial P/L [2019]
190.315,14
Fiinancial P/L [2018]
15.545,844
Fiinancial P/L [2017]
-249.729,097
Financial revenue [2020]
26.892,689
Financial revenue [2019]
71.568,462
Financial revenue [2018]
139.126,567
Financial revenue [2017]
138.747,652
Financial expenses [2020]
-804.906,335
Financial expenses [2019]
-118.746,677
Financial expenses [2018]
123.580,724
Financial expenses [2017]
388.476,749
Net income (Net Income) [2020]
5.047.431,779
Net income (Net Income) [2019]
4.128.449,888
Net income (Net Income) [2018]
2.904.714,694
Net income (Net Income) [2017]
3.746.853,662
82. Su quali criteri si basa la policy di investimento finanziario?
- Doesn't answer
- Assessment based on performance only
- Risk-based assessment
- Assessment based on an internal responsibility code
- Assessment based on parameters of social and environmental impact
- Assessment with certification of ethical rating agencies
83. Quali azioni di ottimizzazione fiscale adottate?
- Doesn't answer
- None
- Allocation of profits generated by companies to the jurisdiction with the lowest tax rate
- Transfer pricing regulation (as provided for in the OECD guidelines)
- Unbound on deductibility of payments made to a country with facilitated taxation
- Non-imposition of withholding tax on transfers of money to countries with facilitated taxation
- Non-introduction of exit taxation from tax havens, to be applied when liquidity is transferred from a country with facilitated taxation to highly taxed countries
- Promotion of voluntary disclosure initiatives to highlight assets held in countries with reduced taxation
84. Promuovete azioni/attività/iniziative di charity (beneficienza)?
-
85. Se Si, indicare URL o elenco attività/associazioni destinatarie
-
86. Indicatori finanziari
Profit per employee (th) [2020]
168,339
Profit per employee (th) [2019]
139,404
Profit per employee (th) [2018]
83,094
Profit per employee (th) [2017]
47,271
Operating revenue per employee (th) [2020]
571,378
Operating revenue per employee (th) [2019]
590,864
Operating revenue per employee (th) [2018]
485,301
Operating revenue per employee (th) [2017]
409,656
Costs of employees / Operating revenue (%) [2020]
n.a.
Costs of employees / Operating revenue (%) [2019]
n.a.
Costs of employees / Operating revenue (%) [2018]
n.a.
Costs of employees / Operating revenue (%) [2017]
n.a.
Average cost of employee (th) [2020]
0
Average cost of employee (th) [2019]
0
Average cost of employee (th) [2018]
0
Average cost of employee (th) [2017]
0
Shareholders' funds for employees (th) [2020]
131,357
Shareholders' funds for employees (th) [2019]
69,012
Shareholders' funds for employees (th) [2018]
221,924
Shareholders' funds for employees (th) [2017]
237,752
Working capital for employees (th) [2020]
192,065
Working capital for employees (th) [2019]
167,646
Working capital for employees (th) [2018]
173,133
Working capital for employees (th) [2017]
155,748
Total assets per employee (th) [2020]
1.085,792
Total assets per employee (th) [2019]
1.040,021
Total assets per employee (th) [2018]
991,415
Total assets per employee (th) [2017]
922,545
ROE using P/L before tax (%) [2020]
128.153
ROE using P/L before tax (%) [2019]
201.999
ROE using P/L before tax (%) [2018]
37.442
ROE using P/L before tax (%) [2017]
19.882
ROCE using P/L before tax (%) [2020]
22.223
ROCE using P/L before tax (%) [2019]
20.597
ROCE using P/L before tax (%) [2018]
12.25
ROCE using P/L before tax (%) [2017]
8.309
ROA using P/L before tax (%) [2020]
15.504
ROA using P/L before tax (%) [2019]
13.404
ROA using P/L before tax (%) [2018]
8.381
ROA using P/L before tax (%) [2017]
5.124
ROE using Net income (%) [2020]
109.786
ROE using Net income (%) [2019]
319.092
ROE using Net income (%) [2018]
32.883
ROE using Net income (%) [2017]
-1.761
ROCE using Net income (%) [2020]
19.189
ROCE using Net income (%) [2019]
31.693
ROCE using Net income (%) [2018]
10.851
ROCE using Net income (%) [2017]
0.069
ROA using Net income (%) [2020]
13.282
ROA using Net income (%) [2019]
21.174
ROA using Net income (%) [2018]
7.361
ROA using Net income (%) [2017]
-0.454
87. Copertura informazioni - indicatore MORE (Multi Objective Rating Evaluation)
100
88. Indicatore OpenCorporation dell'impatto fiscale (%)
Indicatore OC di Impatto Fiscale indica il rapporto % tra la tassazione versata e il valore totale della produzione
Fiscal impact (%) [2020]
4.2225283
Fiscal impact (%) [2019]
2.8136831
Fiscal impact (%) [2018]
1.64795541
Fiscal impact (%) [2017]
-10.95835545
89. Elaborazioni OpenCorporation su Indicatore di impatto fiscale
80
Diversity
90. Avete una policy sulle diversità?
-
91. Sono state adottate misure a sostegno della maternità e della genitorialità dei lavoratori?
Company nurseries
-
Playroom inside the company
-
Agreements with kindergartens/libraries in the vicinity of the company
-
Summer centres
-
Financial contributions for home and/or day-care babysitters
-
Reversible part time
-
Teleworking
-
Work at home
-
Time bank
-
Flexible time in or out
-
Flexibility on shifts
-
Concentrated timetable
-
Employment support upon return from maternity leave or parental leave
-
Training for reintegration after maternity or parental leave
-
92. È stato adottato il bilancio di genere?
-
93. Quali misure specifiche per favorire l’occupazione e la progressione di carriera femminile?
Training courses for the acquisition of specific skills intended solely for female workers
-
Training initiatives in sectors and levels where women are underrepresented
-
Encouraging applications from women for senior posts
-
Change in work organisation to facilitate the reconciliation of living and working time
-
Preference in recruitment of the candidate in case of equal merit with the male candidate
-
Monitoring of recruitment and career advancement of women
-
Study of the situations, levels and sectors in which pay differentials occur
-
Training courses/seminars on equality and equal opportunities for managers and employees
-
94. Organismi/Comitati di pari opportunità in azienda
-
95. Se Sì, con un budget di spesa finanziato dal datore di lavoro?
-
96. Quali misure adottate per l'inclusione di lavoratori/trici con differenza di razza, di origine etnica e/o per la professione dei credi religiosi?
Change in work organisation
-
Granting of permits
-
Flexible time in or out
-
Flexibility on shifts
-
Concentrated timetable
-
97. Utilizzo di lavoro minorile
-
98. Misure di contrasto al lavoro minorile
Not contracted with suppliers using child labor
-
Involves third party entities to monitor the phenomenon
-
Requires its suppliers to terminate their contractual relationships with any subcontractors who use child labor
-
Termination of contractual relationships with suppliers using subcontractors employing minors
-
99. Quali misure adottate per la diffusione della cultura delle differenze e dei diritti umani
Training Courses/Internal Company Seminars
-
Funding of participation in training courses/seminars
-
Promotion and/or support of awareness campaigns
-
100. Condanne giudiziali aventi a oggetto casi di discriminazione e/o di molestie negli ultimi 5 anni?
Discrimination/gender harassment or sexual orientation
-
Discrimination/harassment by age or disability
-
Discrimination/harassment by race or ethnic origin
-
Discrimination/harassment on the grounds of religion or belief
-
101. Condanne giudiziali per motivi sindacali negli ultimi 5 anni?
-
102. Quali misure specifiche fornite per la tutela della salute e della sicurezza delle lavoratrici e in relazione all'età e alla provenienza da altri Paesi?
Provision of gender-differentiated protection measures
-
Provision of age-differentiated protection measures
-
Inclusion in risk assessment
-
Training and supervision in relation to age
-
Training and supervision in relation to provenance
-
103. Coinvolgete i rappresentanti dei lavoratori nell'adozione delle misure sul tema della diversità?
-
Accessibility
104. Avete una policy di accessibilità web?
-
105. Avete una pagina web dedicata alla policy sulla accessibility del sito
-
106. Inserire URL della pagina sulla web policy
-
107. Accessibilità sito web, quali interventi avete applicato
Insertion of Tag Title and Alt in media and hypertext content (for the blind)
-
Use of correct fonts: Georgia, Times New Roman, San Serif, Verdana
-
Backgrounds with contrasting color and text
-
Character magnification with "3 A" positioning in the top right corner
-
Readable website adaptable to all new devices, from smartphones to tablets
-
108. Avete una politica specifica di inserimento lavorativo delle persone con disabilità?
-
109. Se Sì, quali?
Abatement of architectural barriers for disabled motors in every room of the 'company for full use and access to every single service
-
Dismantling of barriers for sensory disabled with tactile paths, sound signal floors, paths to the floors
-
Supply of food suitable for different food needs, including ethnic and religious ones (e.g. intolerances or allergies, celiac disease, kosher, halal, vegetarian, vegan)
-
Adoption of smart working (1) for temporary disabilities (2)
-
110. Se Sì, per quale tipo di disabilità?
People with motor disabilities
-
People with sensory disabilities
-
111. Adottate programmi di formazione/aggiornamento dei lavoratori disabili?
-
112. Se Sì, come?
With qualified staff on the various disabilities with the peer-to-peer principle
-
With external experts
-
With refresher courses and information to all employees
-
113. La vostra azienda ha una politica di accessibilità, facilitazione al lavoro, di strumenti informatici?
-
114. Se Sì per quale tipo di disabilità?
People with motor disabilities
-
People with sensory disabilities
-
115. Coinvolgete i rappresentanti dei lavoratori per l'adozione di misure sul tema di accessibilità delle persone con disabilità?
-
116. Per riunioni/meeting aziendali, quali policy per l’accessibilità esistono?
Abatement of architectural barriers for disabled motors in every room of the 'company for full use and access to every single service
-
Dismantling of barriers for sensory disabled with tactile paths, sound signal floors, paths to the floors
-
Supply of food suitable for different food needs (intolerances or allergies, celiac disease, kosher, halal, vegetarian, vegan)
-
Adoption of smart working (1) for temporary disabilities (2)
-
Environment
117. Avete una policy sull'ambiente?
-
118. Con quale frequenza vengono pubblicati i report di monitoraggio?
- Non-response
- Occasional
- Biannual
- Yearly
119. Coinvolgimento nelle policy di gestione del rischio ambientale
Unilaterally
-
With the workers' representatives
-
With its main suppliers/customers
-
With administrations and civil society directly or indirectly involved
-
120. Si registrano apprezzabili progressi nelle performance ambientali dell’azienda?
-
121. Policy di gestione del rischio ambientale applicata in tutte le sedi in cui l'azienda opera
-
122. Adottate un sistema di Green Public Procurement nei confronti dei fornitori
-
123. Adottate misure per monitorare e ridurre il rischio ambientale
-
124. Realizzate analisi di life cycle assessment?
-
125. Adottate misure di economia circolare e per l'uso efficiente delle materie?
-
126. Utilizzate l'ecodesign e la progettazione per il recupero dei materiali a fine vita?
-
127. Condanne di qualsiasi grado per infrazioni relative all'ambiente negli ultimi 5 anni?
-
128. Elaborazione OpenCorporation dell'indicatore Trucost
60
129. Indicatore ambientale aziendale Trucost
Il punteggio di rischio ambientale (TRUCOST) è la percentuale potenziale di fatturato a rischio nel caso in cui un'azienda debba pagare per il danno ambientale derivante dalle sue attività commerciali.
Year
-
Score
1.48
130. Componenti indicatori ambientali Trucost
Greenhouse gases
0.51
Water
0.56
Waste
0.06
Air pollutants
0.2
Land and water pollutants
0.14
Natural resource use
0.03
131. Trasparenza ambientale
83.65